U.S. markets open in 4 hours 15 minutes
  • S&P Futures

    3,718.50
    -25.75 (-0.69%)
     
  • Dow Futures

    30,059.00
    -130.00 (-0.43%)
     
  • Nasdaq Futures

    12,954.75
    -150.75 (-1.15%)
     
  • Russell 2000 Futures

    2,091.90
    -12.40 (-0.59%)
     
  • Crude Oil

    52.63
    -0.22 (-0.42%)
     
  • Gold

    1,842.80
    -6.10 (-0.33%)
     
  • Silver

    25.29
    -0.10 (-0.39%)
     
  • EUR/USD

    1.2111
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.0140
    0.0000 (0.00%)
     
  • Vix

    34.52
    +11.50 (+49.96%)
     
  • GBP/USD

    1.3646
    -0.0046 (-0.33%)
     
  • USD/JPY

    104.3000
    +0.2280 (+0.22%)
     
  • BTC-USD

    31,600.01
    +539.14 (+1.74%)
     
  • CMC Crypto 200

    636.60
    +8.94 (+1.42%)
     
  • FTSE 100

    6,478.87
    -88.50 (-1.35%)
     
  • Nikkei 225

    28,197.42
    -437.79 (-1.53%)
     

Leap Therapeutics (LPTX) Soars: Stock Adds 8.3% in Session

Zacks Equity Research
·2 min read

Leap Therapeutics, Inc. LPTX was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.99–$2.84 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Leap Therapeutics. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Leap Therapeutics has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Leap Therapeutics, Inc. Price

Leap Therapeutics, Inc. Price
Leap Therapeutics, Inc. Price

Leap Therapeutics, Inc. price | Leap Therapeutics, Inc. Quote


A better-ranked stock in the Medical - Biomedical and Genetics industry is Aerpio Pharmaceuticals, Inc. ARPO, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Leap Therapeutics, Inc. (LPTX) : Free Stock Analysis Report
 
Aerpio Pharmaceuticals, Inc. (ARPO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research